Megan Grabenauer

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Results

Filter by Type

Filter by Year

Filter by Focus Area

Filter by Solution

Filter by Center

Search Results

Analysis of synthetic cannabinoids using high-resolution mass spectrometry and mass defect filtering: Implications for nontargeted screening of designer drugs

The effect of calcium ions and peptide ligands on the relative stabilities of the calmodulin dumbbell and compact structures

Supramolecular modification of ion chemistry: Modulation of peptide charge state and dissociation behavior through complexation with cucurbit[n]uril(n = 5, 6) or α-cyclodextrin

Assessment of cognitive and psychomotor impairment, subjective effects, and blood THC concentrations following acute administration of oral and vaporized cannabis

Evaluation of first generation synthetic cannabinoids on binding at non-cannabinoid receptors and in a battery of in vivo assays in mice

Analytical surveillance of emerging drugs of abuse and drug formulations

Evaluation of the long-term stability of select Phenylacetylindole, Cycloalkylindole, Quinolinyl, and Carboxamide synthetic cannabinoids using LC-MS/MS

Thermolytic degradation of synthetic cannabinoids: Chemical exposures and pharmacological consequences

Evaluation of Laser Diode Thermal Desorption-Tandem Mass Spectrometry (LDTD-MS-MS) in Forensic Toxicology

AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and potency of novel synthetic cannabinoids in producing delta9-tetrahydrocannabinol-like effects in mice

Benzodiazepines reported in NFLIS-Drug, 2015 to 2018

Urinary excretion profile of cannabinoid analytes following acute administration of oral and vaporized cannabis in infrequent cannabis users

Structural analysis of prion proteins using drift cell and traveling wave ion mobility mass spectrometry

Systematic web monitoring of drug test subversion strategies in the United States

Detection and quantification of codeine-6-glucuronide, hydromorphone-3-glucuronide, oxymorphone-3-glucuronide, morphine 3-glucuronide and morphine-6-glucuronide in human hair from opioid users by LC-MS-MS

Oligomers of the prion protein fragment 106-126 are likely assembled from beta-hairpins in solution, and methionine oxidation inhibits assembly without altering the peptide's monomeric conformation

Analytical surveillance of emerging drugs of abuse and drug formulations. [Epub ahead of print] PMID:23154240

Supramolecular modification of ion chemistry: Modulation of peptide charge state and dissociation of behavior through complexation with cucurbit[n]uril (n=5,6) or alpha-cyclodextrin

Prevalence of opioid glucuronides in human hair

Carbon Dioxide as a solubility “switch” for the reversible dissolution of highly fluorinated complexes and reagents in organic solvents: Application to crystallization